Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Niva Bupa, Star Health Get Buy Calls As Nomura Initiates On Four Insurers -- Check Target Prices
Nomura initiated coverage on India's non-life insurance sector with Buy ratings on Niva Bupa and Star Health, while assigning Neutral ratings to ICICI Lombard and PB Fintech amid regulatory uncertainty.
India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boom
India's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. This shift towards preventive care, supported by e-commerce and government initiatives, sees the sector growing at an impressive 10.5% CAGR. While regulatory efforts are strengthening, challenges like consumer awareness and scientific validation persist, yet the industry is poised for significant expansion.
Markets ahead: West Asia tensions, crude prices key factors to watch out
Developments on the geopolitical front, with the latest military exchanges involving the US and Iran, their impact on crude oil prices and domestic macroeconomic data announcements would dictate sentiments in the stock market this week, analysts said. Besides, trading patterns of foreign investors and progress of the southwest monsoon would also remain the key areas of focus for investors, they added. "Market participants will closely monitor Industrial Production (IIP) data, the final HSBC Manufacturing, Services and Composite PMI readings, and the foreign exchange reserves data for fresh insights into the health of the domestic economy," Ajit Mishra, SVP, Research, Religare Broking Ltd, said. Globally, the trajectory of crude oil prices and geopolitical developments in West Asia will remain key drivers of market sentiment, he said. The monthly auto sales numbers on July 1 will also be tracked by investors closely. "The week ahead is likely to be shaped by developments on the ..
SIPs Over Health? 51% GenZ Invest But Postpone Buying Insurance Cover, Says Report
Digital platforms are shaping insurance awareness but not necessarily buying behaviour.
Healthcare demand is outstripping supply in Noida, says MOFSL; prefers Medanta, Max Healthcare
Noida-Greater Noida is rapidly becoming a prime healthcare hub in North India, fueled by population growth and corporate expansion. Despite increasing capacity, the region faces a significant shortage of super-specialty beds. Strong demand for various medical services is evident, with hospitals experiencing rising occupancy and robust revenue. Infrastructure development further bolsters the market's long-term potential, though doctor availability remains a challenge.
Shelf-life norms for imported drugs may be relaxed to reduce wastage
India is set to revise rules for imported medicines, proposing a 12-month minimum residual shelf life instead of the current 60% rule. This aims to ease business and reduce wastage, particularly for drugs with longer expiry dates. However, biological and radiopharmaceutical products will retain the stricter 60% requirement due to public health concerns. Other quality and safety regulations remain unchanged.
Health ministry issues proposal for one-year residual shelf life for imported drugs
The Union Health Ministry is proposing to relax import rules for medicines, requiring a minimum 12-month shelf life upon arrival instead of the current 60% of total shelf life. This move aims to simplify business operations and ensure medicine availability. The change, however, will not affect specialized drugs like biologicals and radiopharmaceuticals. Officials believe this will cut down wastage and improve inventory management, ultimately benefiting patients.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Volumes jump at Global Health Ltd counter
Global Health Ltd saw volume of 10.02 lakh shares by 10:46 IST on BSE, a 60.42 fold spurt over two-week average daily volume of 16586 shares
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence Pharma
Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry into the health and wellness supplements market. This strategic move aims to leverage Fluence's patented technology and dermatologist network to expand Honasa's 'inside-out' beauty solutions. The acquisition is expected to significantly boost Honasa's growth by diversifying its product portfolio into the rapidly expanding Indian nutraceuticals sector.
Need to cut chemical fertilisers usage via crop diversification, incentives: EAC-PM Chairman
India must curb chemical fertilizer use by promoting crop diversification, natural farming, and productivity-linked incentives, stated EAC-PM Chairman S Mahendra Dev. He stressed the need for a sustainable, resilient farm sector to achieve developed nation status by 2047. Dev highlighted reforms like soil health cards and nano-urea, advocating for a National Nutrient Use Efficiency Initiative and a nutrient credit system to boost soil health and productivity.
Central Drugs Laboratories find 46 drug samples not of standard quality for May
Health officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratories were found to be of substandard quality. Additionally, one spurious drug, manufactured by an unauthorized entity using another company's brand, was identified in Assam and is under investigation. These findings highlight ongoing efforts to ensure drug safety and remove substandard products from circulation.